NCT03957577View on ClinicalTrials.gov

Etiology of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) in Japan

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

June 13, 2019

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
OTHER

Prospective observational cohort study

Prospective observational cohort study

Trial Locations (13)

807-8555

GSK Investigational Site, Fukuoka

811-1394

GSK Investigational Site, Fukuoka

820-8505

GSK Investigational Site, Fukuoka

960-1295

GSK Investigational Site, Fukushima

734-8530

GSK Investigational Site, Hiroshima

515-8544

GSK Investigational Site, Mie

859-0497

GSK Investigational Site, Nagasaki

940-2085

GSK Investigational Site, Niigata

560-8552

GSK Investigational Site, Osaka

591-8555

GSK Investigational Site, Osaka

596-8501

GSK Investigational Site, Osaka

438-8550

GSK Investigational Site, Shizuoka

142-8666

GSK Investigational Site, Tokyo

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT03957577 - Etiology of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) in Japan | Biotech Hunter | Biotech Hunter